Anovel mechanism of tumor progression by the candidate tumor suppressor Proxl : RNA mutation in cancer
Anovel mechanism of tumor progression by the candidate tumor suppressor Proxl : RNA mutation in cancer
批准号:
18390345
负责人:
KUBO Hajime
金额:
$11.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
1. 我们发现Prox1的表达与肝细胞癌的分化程度有关。在体外和体内转染prox1基因可抑制癌细胞的生长。相比之下,prox1的siRNA在体外促进癌细胞的生长。这些发现提示Prox1可能具有肿瘤抑制作用。【意义】已知果蝇普洛斯彼罗在神经干细胞的不对称细胞分裂过程中起作用。不对称细胞分裂紊乱与肿瘤的关系在哺乳动物中得到证实。prox1的RNA突变促进了癌症的进展。我们在癌细胞中发现了prox1基因的4个常见位点的RNA突变。另一方面,在细胞中没有发现这些位点的基因突变。这些突变都是A-I突变,表明RNA编辑参与了癌症的进展。转染突变体形式的prox1在癌细胞中没有显示出抑制作用。【意义】传统上,癌症被认为是基因突变的产物。然而,在这里,我们发现RNA突变可以促进癌症的形成。令人惊讶的是,这些突变在人类样本中被发现。这一新概念可能为癌症治疗提供新的靶点,即。RNA突变的分子机制。
英文摘要
1. Homeobox gene, Prox1 acts as tumor suppressorWe showed that the expression of Prox1 was associated with the differentiation grades in hepatocellular carcinoma using human samples. Transfection of prox1 gene in cancer cells suppressed the growth in vitro and in vivo. In contrast, siRNA for prox1 promoted the growth of cancer cells in vitro. These findings suggested that Prox1 may act as tumor suppressor.[Significance]Drosophila, Prospero, has been known to function during the asymmetric cell division of neural stem cells. The relationship between the disorder of asymmetric cell division and cancer could be confirmed in mammal.2. RNA mutation of prox1 promotes cancer progression.We found RNA mutation in 4 common sites of prox1 gene in cancer cells. On the other hand, genetic mutations in the sites were not found in the cells. These mutations were all A-I mutation, suggesting the involvement of RNA editing in cancer progression. The transfection of mutant form of prox1 did not show the suppressive function in cancer cells.[Significance]Classically, cancer is believed to be the product of the genomic mutation. However, here, we found that RNA mutations could promote the cancer formation. Surprisingly, these mutations were found in human samples. The novel concept may provide the new target of cancer therapy, ie. the molecular mechanism of RNA mutations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/01.atv.0000225770.57219.b0
发表时间:
2006-09-01
期刊:
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
影响因子:
8.7
作者:
[Kono, Tomoya, Kubo, Hajime, Yamashita, Jun K.]
通讯作者:
Yamashita, Jun K.
Two populations OF Thyl-positive mesenchymal cells regulate the in vitro maturation of hepatic progenitor cells.
两个Thyl阳性间充质细胞群调节肝祖细胞的体外成熟。
DOI:
--
发表时间:
2007
期刊:
Am J Physiol Gastr Liver Physiol. 292
影响因子:
--
作者:
[Kamo N, Yasuchika K. Ishii T, Fujita N, Tsuruo T, Yamashita JK, Kubo H, Ikai I]
通讯作者:
Ikai I
RNA mutations of proxl detected in human esophageal cancer cells by the shifted termination assay.
通过转移终止试验在人食管癌细胞中检测到 proxl 的 RNA 突变。
DOI:
--
发表时间:
2007
期刊:
BBRC 359
影响因子:
--
作者:
[Yoshimoto T, Takahashi M, Nagayama S, Watanabe G, Shimada Y, Sakai Y, Kubo H]
通讯作者:
Kubo H
A homeobox protein proxl is involved in the differentiation, proliferation and prognosis in hepatocellular carcinoma
同源盒蛋白proxl参与肝细胞癌的分化、增殖和预后
DOI:
--
发表时间:
2006
期刊:
Clin Can Res 12(20)
影响因子:
--
作者:
[Shimoda, M., Takahashi, M., Yoshimoto, T., Kono, T, Ikai, I., Kubo, H]
通讯作者:
H
DOI:
10.1177/1947601911423028
发表时间:
2011-12-01
期刊:
Genes & cancer
影响因子:
--
作者:
[Christiansen, Ailsa, Detmar, Michael]
通讯作者:
Detmar, Michael
共 6 条
Targeting therapy against cancer stem cells
-
批准号:20390341
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:KUBO Hajime
-
依托单位:
Lymphangiogenesis in cancer
-
批准号:17014047
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$29.06万
-
财政年份:2005
-
负责人:KUBO Hajime
-
依托单位:
Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis
-
批准号:16390378
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2004
-
负责人:KUBO Hajime
-
依托单位:
海外基金